title: The role of protein solubilization in antigen removal from xenogeneic tissue for heart valve tissue engineering.
abstract: Decellularization techniques have been developed in an attempt to reduce the antigenicity of xenogeneic biomaterials, a critical barrier in their use as tissue engineering scaffolds. However, numerous studies have demonstrated inadequate removal and subsequent persistence of antigens in the biomaterial following decellularization, resulting in an immune response upon implantation. Thus, methods to enhance antigen removal (AR) are critical for the use of xenogeneic biomaterials in tissue engineering and regenerative medicine. In the present study, AR methods incorporating protein solubilization principles were investigated for their ability to reduce antigenicity of bovine pericardium (BP) for heart valve tissue engineering. Bovine pericardium following AR (BP-AR) was assessed for residual antigenicity, tensile properties, and extracellular matrix composition. Increasing protein solubility during AR significantly decreased the residual antigenicity of BP-AR-by an additional 80% compared to hypotonic solution or 60% compared to 0.1% (w/v) SDS decellularization methods. Moreover, solubilizing agents have a dominant effect on reducing the level of residual antigenicity of BP-AR beyond that achieved by AR additives alone. Tested AR methods did not compromise the tensile properties of BP-AR compared to native BP. Furthermore, residual cell nuclei did not correlate to residual antigenicity, demonstrating that residual nuclei counts may not be an appropriate indicator of successful AR. In conclusion, AR strategies promoting protein solubilization significantly reduced residual antigens compared to decellularization methods without compromising biomaterial functional properties. This study demonstrates the importance of solubilizing protein antigens for their removal in the generation of xenogeneic scaffolds.
authors.affiliation: Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA.
authors.forename: Maelene L
authors.initials: ML
authors.lastname: Wong
authors.forename: J Kent
authors.initials: JK
authors.lastname: Leach
authors.forename: Kyriacos A
authors.initials: KA
authors.lastname: Athanasiou
authors.forename: Leigh G
authors.initials: LG
authors.lastname: Griffiths
mesh_terms: D000818:Animals; D000941:Antigens / Q000302:isolation & purification*; D015153:Blotting, Western; D002021:Buffers; D002417:Cattle; D004229:Dithiothreitol / Q000737:chemistry; D006350:Heart Valve Prosthesis; D010496:Pericardium / Q000166:cytology / Q000378:metabolism; D011189:Potassium Chloride / Q000737:chemistry; D011506:Proteins / Q000737:chemistry*; D012995:Solubility; D013718:Tensile Strength; D023822:Tissue Engineering / Q000379:methods*
chemical_list: D000941:Antigens; D002021:Buffers; D011506:Proteins; D011189:Potassium Chloride; D004229:Dithiothreitol